Network Pharmacology, Bioinformatics Analysis, and Experimental Validation to Reveal the Target, and Pharmacological Mechanism of DHDK in Treating Breast Cancer

Scientists combined network pharmacology, bioinformatics, molecular docking, and experimental verification to elucidate the mechanism of action of (1E,4E)- 1,7-bis(4-hydroxyphenyl)hepta- 1,4-dien- 3-one (DHDK) in treating breast cancer.